Who Buys Serum from India — 897 Importers Behind a $27.1M Market
India's serum import market is served by 897 active buyers who collectively imported $27.1M across 15,000 shipments. BSV BIOSCIENCE PHILS. INC (PHILIPPINES) leads with a 5.7% market share, followed by CUST ID: BILTP and AFRI FARMACIA LDA AVENIDA DAS FPLM N. The top 5 buyers together control 21.0% of total import value, reflecting a moderately competitive buyer landscape.
Top Serum Importers — Ranked by Import Value
BSV BIOSCIENCE PHILS. INC (PHILIPPINES) is the leading serum importer from India, holding a 5.7% share of the $27.1M market across 15,000 shipments from 897 buyers. The top 5 buyers — BSV BIOSCIENCE PHILS. INC (PHILIPPINES), CUST ID: BILTP (PHILIPPINES), AFRI FARMACIA LDA AVENIDA DAS FPLM N (MOZAMBIQUE), DLCNB (THAILAND), BSV BIOSCIENCE PHILIPPHINES INC (PHILIPPINES) — collectively control 21.0% of total import value.
Top Serum Buyers & Importers
Ranked by import value · 897 active buyers · Indian Customs (DGFT) data
| # | Buyer & Formulations | Value | Suppliers | Share |
|---|---|---|---|---|
| 1 | BSV BIOSCIENCE PHILS. INCPHILIPPINES EQUIRAB 1000IU/5ML [RABIES ANTISERUM-EQUEQUIRAB 1000IU/5ML [RABIES ANTISERUM - EQUINE]RABIES ANTISERUM VLS | $1.5M | 5 | 5.7% |
| 2 | CUST ID: BILTPPHILIPPINES EQUIRAB 1000IU/5ML [RABIES ANTISERUM - EQUINE]EQUIRAB 1000IU/5ML [RABIES ANTISERUM-EQUEQUIRAB 1000 IU/5ML [ RABIES ANTISERUM -EQUINE] | $1.2M | 5 | 4.4% |
| 3 | AFRI FARMACIA LDA AVENIDA DAS FPLM NMOZAMBIQUE EQUIRAB 1000 IU/ 5ML RABIES ANTISERUM -SNAKE VENOM ANTISERUM AFRICAN 10 - LYOTUBERVAC BCG SERUM | $987.9K | 5 | 3.6% |
| 4 | DLCNBTHAILAND EQUIRAB 1000 IU/5ML [ RABIES ANTISERUM -EQUINE]RABIES ANTISERUM 1000 I.U. I.H.S. & (VINRAB 1000IU LIQUID+EQUIRAB (1000 IU/5ML RABIES ANTISERUM-E | $986.7K | 5 | 3.6% |
| 5 | BSV BIOSCIENCE PHILIPPHINES INCPHILIPPINES EQUIRAB 1000IU/5ML [RABIES ANTISERUM-EQUEQUIRAB 1000IU/5ML [RABIES ANTISERUM - EQUINE]RABIES ANTISERUM VLS | $985.0K | 5 | 3.6% |
| 6 | TO BIONET-ASIA CO LTDTHAILAND EQUIRAB 1000IU/5ML [RABIES ANTISERUM-EQUEQUIRAB 1000 IU/5ML [ RABIES ANTISERUM -EQUINE]EQUIRAB 1000IU/5ML [RABIES ANTISERUM - EQUINE] | $804.5K | 5 | 3.0% |
| 7 | JINYE INTERNATIONAL LOGISTICS LTDHONG KONG FETAL BOVINE SERUM, QUALIFIED, E.U.-APPRFETAL BOVINE SERUM STANDARD PARTFETAL BOVINE SERUM, STANDARD PAR | $766.7K | 5 | 2.8% |
| 8 | PHARMACIE CENTRALE DETUNISIA EQUIRAB 1000 IU/5ML [RABIES ANTISERUMEQUIRAB 1000 IU 5ML RABIES ANTISERUM EQUINEEQUIRAB 1000 IU/5MLRABIES ANTISERUM - EQUINE | $720.2K | 5 | 2.7% |
| 9 | INSTITUT PASTEUR D ALGERIEALGERIA EQUIRAB 1000IU/5ML [RABIES ANTISERUM - EQUINE]EQUIRAB 1000IU/5ML [RABIES ANTISERUM - EEQUIRAB 1000IU/5ML [RABIES ANTISERUM -EQUINE] | $716.8K | 5 | 2.6% |
| 10 | JINYE INTERNATIONAL LOGISTICSHONG KONG FETAL BOVINE SERUM, QUALIFIED, E.U.-APPRFETAL BOVINE SERUM STANDARD PARTFETAL BOVINE SERUM, STANDARD PAR | $691.3K | 5 | 2.5% |
| 11 | BSV BIOSCIENCE PHILS INCPHILIPPINES EQUIRAB 1000IU/5ML [RABIES ANTISERUM-EQUEQUIRAB 1000IU/5ML [RABIES ANTISERUM - EQUINE]RABIES ANTISERUM VLS | $647.5K | 5 | 2.4% |
| 12 | HABIB BANK LIMITEDPAKISTAN SNAKE VENOM ANTISERUM LYOPHILIZEDEQUIRAB 1000 IU/5ML [ RABIES ANTISERUM -EQUINE]SNAKE VENOM ANTISERUM | $531.7K | 5 | 2.0% |
| 13 | CONSIGNEE NAME & ADDRESS AS PER EXPRUSSIA SURE FETAL BOVINE SERUM - RM10971EX-CELL 420 SERUM-FREE MEDIUM FOR INSECTSURE FETAL BOVINE SERUM | $508.3K | 5 | 1.9% |
| 14 | STATE PHARMACEUTICALS CORPORATIONSRI LANKA SNAKE VENOM ANTISERUM IP LYOPHILISEDEQUIRAB 1000 IU/ 5ML [RABIES ANTISERUM-EEQUIRAB 1000 IU 5ML RABIES ANTISERUM EQUINE | $477.5K | 5 | 1.8% |
| 15 | INSTITUT PASTEUR DALGERIEALGERIA EQUIRAB 1000IU/5ML [RABIES ANTISERUM - EQUINE]EQUIRAB 1000IU/5ML [RABIES ANTISERUM - EEQUIRAB 1000IU/5ML [RABIES ANTISERUM -EQUINE] | $474.1K | 5 | 1.7% |
Related Analysis
Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Which companies are buying Serum — and from which countries?
Flow of Serum exports from India: each country's share and the named importers behind the numbers
Serum — Buyer Countries to Key Importers
Trade flow: top importing countries → named buyer companies
Market Analysis: Top Importing Countries & Their Importers
1Philippines
Philippines emerges as the first largest importing country, achieving a total trade value of $5.6M through 24 shipments. This represents a market share of 20.7% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Philippines has a diverse importer base, with their top importers including:
• BSV BIOSCIENCE PHILS. INC - $1.5M (27.4% of country's total business)
• CUST ID: BILTP - $1.2M (21.3% of country's total business)
• BSV BIOSCIENCE PHILIPPHINES INC - $985.0K (17.5% of country's total business)
• BSV BIOSCIENCE PHILS INC - $647.5K (11.5% of country's total business)
• BSV BIOSCIENCE PHILIPPINES INC - $391.1K (7.0% of country's total business)
• Rest of Philippines's importers - $863.5K (15.4% of country's total business)
Key Insight: Philippines demonstrates strong market positioning with an average shipment value of $234.4K, indicating premium pricing strategy compared to the market average of $1.8K.
Philippines is a key market for Serum imports, representing 20.7% of total trade value.
2Thailand
Thailand emerges as the second largest importing country, achieving a total trade value of $2.7M through 11 shipments. This represents a market share of 9.8% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Thailand has a diverse importer base, with their top importers including:
• DLCNB - $986.7K (37.2% of country's total business)
• TO BIONET-ASIA CO LTD - $804.5K (30.3% of country's total business)
• CUST ID:DLCNB - $344.3K (13.0% of country's total business)
Key Insight: Thailand demonstrates strong market positioning with an average shipment value of $241.2K, indicating premium pricing strategy compared to the market average of $1.8K.
Thailand is a key market for Serum imports, representing 9.8% of total trade value.
3Algeria
Algeria emerges as the third largest importing country, achieving a total trade value of $2.1M through 10 shipments. This represents a market share of 7.7% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Algeria has a diverse importer base, with their top importers including:
• INSTITUT PASTEUR D ALGERIE - $716.8K (34.3% of country's total business)
• INSTITUT PASTEUR DALGERIE - $474.1K (22.7% of country's total business)
Key Insight: Algeria demonstrates strong market positioning with an average shipment value of $209.1K, indicating premium pricing strategy compared to the market average of $1.8K.
Algeria is a key market for Serum imports, representing 7.7% of total trade value.
4Hong Kong
Hong Kong emerges as the fourth largest importing country, achieving a total trade value of $1.9M through 15 shipments. This represents a market share of 6.8% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Hong Kong has a diverse importer base, with their top importers including:
• JINYE INTERNATIONAL LOGISTICS LTD - $766.7K (41.3% of country's total business)
• JINYE INTERNATIONAL LOGISTICS - $691.3K (37.3% of country's total business)
Key Insight: Hong Kong demonstrates strong market positioning with an average shipment value of $123.6K, indicating premium pricing strategy compared to the market average of $1.8K.
Hong Kong is a key market for Serum imports, representing 6.8% of total trade value.
5Russia
Russia emerges as the fifth largest importing country, achieving a total trade value of $1.5M through 3 shipments. This represents a market share of 5.4% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Russia has a diverse importer base, with their top importers including:
• CONSIGNEE NAME & ADDRESS AS PER EXP - $508.3K (34.6% of country's total business)
Key Insight: Russia demonstrates strong market positioning with an average shipment value of $489.9K, indicating premium pricing strategy compared to the market average of $1.8K.
Russia is a key market for Serum imports, representing 5.4% of total trade value.
Buyer Segment Analysis
TransData Nexus Serum buyer market intelligence
1Buyer Segment Analysis
The importation of Serum from India involves various buyer segments, each with distinct purchasing behaviors and order patterns.
Distributors: Entities like BSV Bioscience Phils. Inc. in the Philippines and Jinye International Logistics Ltd in Hong Kong function as intermediaries, procuring Serum in bulk to supply to healthcare providers and retailers. Their purchasing behavior is characterized by large, regular orders to maintain a steady supply chain.
Hospital Groups: Organizations such as Institut Pasteur d'Algérie in Algeria and DLCNB in Thailand represent hospital groups that import Serum directly for patient treatment. Their order patterns are typically consistent, aligning with patient demand and treatment protocols.
Government Procurement: Entities like Pharmacie Centrale de in Tunisia engage in centralized procurement for public healthcare facilities. Their purchasing behavior is often characterized by large-volume orders through formal tender processes, ensuring cost-effectiveness and supply stability.
Re-exporters: Companies such as Jinye International Logistics Ltd in Hong Kong may also act as re-exporters, importing Serum for redistribution to other markets. Their order patterns can be irregular, influenced by market demand fluctuations and trade agreements.
Country-Specific Import Regulations
TransData Nexus Serum buyer market intelligence
1Country-Specific Import Regulations
Philippines:
Thailand:
Algeria:
Hong Kong:
Russia:
Demand Drivers & Market Opportunity
TransData Nexus Serum buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Serum in importing countries is driven by several factors:
Disease Prevalence: High incidence rates of diseases treatable with Serum, such as snake bites and certain infections, necessitate substantial imports. For instance, the World Health Organization (WHO) reported in 2024 that snakebite envenoming causes approximately 81,000 to 138,000 deaths annually, predominantly in tropical and subtropical regions.
Government Healthcare Programs: Many countries have implemented programs to provide essential medicines, including Serum, to their populations. The WHO's Essential Medicines List, updated in 2025, includes various Serums, guiding national procurement strategies. Additionally, the expansion of universal health coverage in countries like the Philippines and Thailand has increased the demand for such essential medicines.
With 897 buyers across 122 countries, the market for Serum presents significant opportunities for exporters. Tender-based purchasing by governments and international organizations ensures a steady demand, while the inclusion of Serum in global health initiatives underscores its critical role in public health.
Common Questions — Serum Buyers & Importers
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
QWho is the largest serum buyer importing from India?
Based on import volume and value, BSV BIOSCIENCE PHILS. INC (PHILIPPINES) leads with $1.5M in imports and a 5.7% market share — the highest of any single serum importer. CUST ID: BILTP (PHILIPPINES) and AFRI FARMACIA LDA AVENIDA DAS FPLM N (MOZAMBIQUE) are the next largest buyers.
QHow many companies buy serum from India?
There are 897 active serum buyers importing from India, with a combined market of $27.1M across 15,000 shipments to 122 countries. The top 5 buyers hold 21.0% of total import value, while the remaining 892 buyers handle the other 79.0%.
QWhich countries import the most serum from India?
The top importing countries for serum from India are Philippines (20.7%), Thailand (9.8%), Algeria (7.7%), Hong Kong (6.8%), Russia (5.4%). These markets represent the largest demand centres for Indian pharmaceutical exports of serum, with buyers ranging from government procurement agencies to private pharmaceutical distributors.
QWhat is the average import order value for serum from India?
The average import transaction value for serum from India is $1.8K, with an average unit price of $36.03 per unit. Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.
Buyer Segment Analysis
TransData Nexus Serum buyer market intelligence
1Buyer Segment Analysis
The importation of Serum from India involves various buyer segments, each with distinct purchasing behaviors and order patterns.
Distributors: Entities like BSV Bioscience Phils. Inc. in the Philippines and Jinye International Logistics Ltd in Hong Kong function as intermediaries, procuring Serum in bulk to supply to healthcare providers and retailers. Their purchasing behavior is characterized by large, regular orders to maintain a steady supply chain.
Hospital Groups: Organizations such as Institut Pasteur d'Algérie in Algeria and DLCNB in Thailand represent hospital groups that import Serum directly for patient treatment. Their order patterns are typically consistent, aligning with patient demand and treatment protocols.
Government Procurement: Entities like Pharmacie Centrale de in Tunisia engage in centralized procurement for public healthcare facilities. Their purchasing behavior is often characterized by large-volume orders through formal tender processes, ensuring cost-effectiveness and supply stability.
Re-exporters: Companies such as Jinye International Logistics Ltd in Hong Kong may also act as re-exporters, importing Serum for redistribution to other markets. Their order patterns can be irregular, influenced by market demand fluctuations and trade agreements.
Country-Specific Import Regulations
TransData Nexus Serum buyer market intelligence
1Country-Specific Import Regulations
Philippines:
Thailand:
Algeria:
Hong Kong:
Russia:
Demand Drivers & Market Opportunity
TransData Nexus Serum buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Serum in importing countries is driven by several factors:
Disease Prevalence: High incidence rates of diseases treatable with Serum, such as snake bites and certain infections, necessitate substantial imports. For instance, the World Health Organization (WHO) reported in 2024 that snakebite envenoming causes approximately 81,000 to 138,000 deaths annually, predominantly in tropical and subtropical regions.
Government Healthcare Programs: Many countries have implemented programs to provide essential medicines, including Serum, to their populations. The WHO's Essential Medicines List, updated in 2025, includes various Serums, guiding national procurement strategies. Additionally, the expansion of universal health coverage in countries like the Philippines and Thailand has increased the demand for such essential medicines.
With 897 buyers across 122 countries, the market for Serum presents significant opportunities for exporters. Tender-based purchasing by governments and international organizations ensures a steady demand, while the inclusion of Serum in global health initiatives underscores its critical role in public health.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Buyer Identification: 897 global importers of Serum identified from consignee fields in DGFT shipping bill records.
- 2.Import Value Analysis: Total import value aggregated from 15,000 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Geographic Distribution: Buyer imports distributed across 122 destination countries with market share per buyer calculated from capped values.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
15,000 Verified Shipments
897 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists